European Commission Approves KEYTRUDA® as First-Line Treatment in Adult Patients With Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer Pharmaceutical Investing
European Commission Approves AbbVie's RINVOQ for the Treatment of Psoriatic Arthritis and Ankylosing Spondylitis Biotech Investing
Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL002 in Individuals with Early Alzheimer's Disease Biotech Investing
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates Pharmaceutical Investing
European Commission Approves BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma Pharmaceutical Investing
FDA Approves Aurinia Pharmaceuticals' LUPKYNIS for Adult Patients with Active Lupus Nephritis Biotech Investing
U.S. Food and Drug Administration Approves OPDIVO® in Combination with CABOMETYX® as First-line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19 Pharmaceutical Investing
